$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-09-04 AccNo: 0001193125-18-265422 Size: 35 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接